1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Auxly Cannabis Group Inc.
  6. Summary
    XLY   CA05335P1099

AUXLY CANNABIS GROUP INC.

(XLY)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
05/10/2022 05/11/2022 05/12/2022 05/13/2022 05/16/2022 Date
0.165(c) 0.155(c) 0.145(c) 0.17(c) 0.155 Last
791 057 1 216 467 3 303 191 8 504 910 2 314 376 Volume
+6.45% -6.06% -6.45% +17.24% -8.82% Change
More quotes
Estimated financial data (e)
Sales 2022 107 M 82,6 M 82,6 M
Net income 2022 -69,7 M -54,0 M -54,0 M
Net Debt 2022 187 M 145 M 145 M
P/E ratio 2022 -1,86x
Yield 2022 -
Sales 2023 166 M 129 M 129 M
Net income 2023 -20,9 M -16,2 M -16,2 M
Net Debt 2023 218 M 169 M 169 M
P/E ratio 2023 -5,81x
Yield 2023 -
Capitalization 138 M 107 M 107 M
EV / Sales 2022 3,05x
EV / Sales 2023 2,14x
Nbr of Employees 558
Free-Float 79,1%
More Financials
Company
Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products for wellness and recreational consumers. The Company's segments include Canadian cannabis operations and South American cannabis operations. Both segments are engaged in the cultivation and sale of cannabis products... 
Sector
Pharmaceuticals
Calendar
05/30Earnings Release
More about the company
Ratings of Auxly Cannabis Group Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about AUXLY CANNABIS GROUP INC.
09:07aDelta 9 Cannabis Q1 EPS Loss Unchanged at $0.04 From Year Ago; Net Revenue Falls 6% to ..
MT
08:30aAuxly Cannabis Group Reports Wider Q1 Loss, Higher Revenue
MT
07:26aAUXLY CANNABIS GROUP BRIEF : Cites Loss of $29.4 Million Relative to Same Period in 2021 P..
MT
07:25aAUXLY CANNABIS GROUP BRIEF : Net Loss From Continuing Op $39.846 Million Representing a Ne..
MT
07:22aAUXLY CANNABIS GROUP BRIEF : Details 47% Increase in Net Sales Vs Q1 in 2021, Recorded Net..
MT
04:39aHygrovest Divesting Investment in Entourage Health
MT
05/13Delta 9 Cannabis Up 6% At Last Look On Q1 Revenue Guidance
MT
05/13Toronto index rebounds on energy, tech boost
RE
05/1322nd Century Group Acquires Cannabis Firm GVB Biopharma
MT
05/13Greenlane Signs Distribution Deal for Latin America Markets
MT
05/13PIPER SANDLER ON AURORA CANNABIS : "Profitability On The Horizon"
MT
05/12Aurora Cannabis Reports Q3 Net Revenue of $50.4 Million, Shutting Edmonton Sky Facility..
MT
05/12GUIDANCE : (ACB.TO) AURORA CANNABIS Says Remains #1 Canadian LP in High Margin Global Medi..
MT
05/12GUIDANCE : (ACB.TO) AURORA CANNABIS Reiterating Adjusted EBITDA Profitability Run Rate by ..
MT
05/12Earnings Flash (ACB.TO) AURORA CANNABIS Reports Q3 2022 total cannabis net revenue was ..
MT
More news
News in other languages on AUXLY CANNABIS GROUP INC.
09:07aDELTA 9 CANNABIS : perte de bénéfice par action au premier trimestre inchangée à 0,04 $ pa..
08:30aAuxly Cannabis Group annonce une perte plus importante au premier trimestre, mais une h..
05/13Delta 9 Cannabis en hausse de 6 % au dernier regard sur les prévisions de revenus pour ..
05/13L'indice de Toronto rebondit grâce à l'énergie et aux technologies
05/1322nd Century Group acquiert la société de cannabis GVB Biopharma
More news
Analyst Recommendations on AUXLY CANNABIS GROUP INC.
More recommendations
Chart AUXLY CANNABIS GROUP INC.
Duration : Period :
Auxly Cannabis Group Inc. Technical Analysis Chart | XLY | CA05335P1099 | MarketScreener
Technical analysis trends AUXLY CANNABIS GROUP INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 0,16 CAD
Average target price 0,34 CAD
Spread / Average Target 118%
EPS Revisions
Managers and Directors
Hugo M. Alves Director
Michael Lickver President
Brian Schmitt Chief Financial Officer
Genevieve Young Chairman
Alan Cooke Senior Vice President-Operations